# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-25-011169
Filing Date
2025-03-31
Accepted
2025-03-31 07:50:37
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | ef20039001_10k.htm iXBRL | 10-K | 2216782
2 | EXHIBIT 10.21 | ef20039001_ex10-21.htm | EX-10.21 | 101684
3 | EXHIBIT 19 | ef20039001_ex19.htm | EX-19 | 80001
4 | EXHIBIT 21.1 | ef20039001_ex21-1.htm | EX-21.1 | 3237
5 | EXHIBIT 23.1 | ef20039001_ex23-1.htm | EX-23.1 | 3030
6 | EXHIBIT 31.1 | ef20039001_ex31-1.htm | EX-31.1 | 12454
7 | EXHIBIT 31.2 | ef20039001_ex31-2.htm | EX-31.2 | 12476
8 | EXHIBIT 32.1 | ef20039001_ex32-1.htm | EX-32.1 | 5140
9 | EXHIBIT 32.2 | ef20039001_ex32-2.htm | EX-32.2 | 5147
| Complete submission text file | 0001140361-25-011169.txt |  | 10577837

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA | galt-20241231.xsd | EX-101.SCH | 83333
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | galt-20241231_cal.xml | EX-101.CAL | 44681
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | galt-20241231_def.xml | EX-101.DEF | 423018
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | galt-20241231_lab.xml | EX-101.LAB | 1011827
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | galt-20241231_pre.xml | EX-101.PRE | 637020
95 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20039001_10k_htm.xml | XML | 1449634

Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 25788957
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)